Information
News News
- Information
Articles on the Joint Research Agreement Between Elix and the University of Vienna for AI-Driven Drug Discovery Featured in International Media
- News Release
Elix, an AI Drug Discovery Company and University of Vienna Enter into Joint Research Agreement to Advance Drug Discovery Using AI Technology
- Information
Elix will exhibit at the AI-Driven Drug Discovery Forum on July 14
MedChem’s ultimate partner for AI drug discovery,
from predictive and generative models with an intuitive UI to expert consulting, all in a single package.
Data Advantage:
16 Pharma Partners
AI models trained on proprietary data from 16 pharma partners, covering activity, ADME, and toxicity.
Novel Structures
Beyond Human ImaginationDesigns novel, non-obvious structures, proven across multiple programs.
PhD-Led Consulting & Support
Experienced PhD scientists provide hands-on onboarding, workflow integration, and ongoing support.
Partners
Our Clients and Partners
We are collaborating with pharmaceutical companies, academic institutes, and drug discovery start-ups.
